or Try an Advanced Search...

    Technical Analysis for BCTX - BriaCell Therapeutics Corp.

    Grade Last Price % Change Price Change
    F 0.65 -3.99% -0.03
    BCTX closed down 3.99 percent on Tuesday, November 12, 2024, on 8 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BCTX trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness -3.99%
    Wide Bands Range Expansion -3.99%
    Lower Bollinger Band Touch Weakness -3.99%
    Oversold Stochastic Weakness -3.99%
    180 Bearish Setup Bearish Swing Setup -6.47%
    Older End-of-Day Signals for BCTX ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 4 hours ago
    Down 5% about 6 hours ago
    Down 3% about 6 hours ago
    Fell Below Lower Bollinger Band about 6 hours ago
    60 Minute Opening Range Breakdown about 6 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BCTX Chart by TradingView
    Basic chart:

    Profile

    BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer

    Is BCTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 8 BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
    Nov 4 BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
    Oct 22 BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns
    Oct 22 BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study
    Oct 22 BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
    Oct 15 BriaCell gains after update on late-stage trial for lead asset
    Oct 15 BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
    Oct 2 BriaCell Therapeutics Announces Closing of $5 Million Offering
    Oct 2 Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
    Oct 1 BriaCell Therapeutics Announces $5 Million Offering
    See more BCTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.97
    52 Week Low 0.4641
    Average Volume 6,258,038
    200-Day Moving Average 1.66
    50-Day Moving Average 0.79
    20-Day Moving Average 0.79
    10-Day Moving Average 0.73
    Average True Range 0.09
    RSI (14) 37.50
    ADX 20.07
    +DI 17.96
    -DI 26.12
    Chandelier Exit (Long, 3 ATRs) 0.70
    Chandelier Exit (Short, 3 ATRs) 0.89
    Upper Bollinger Bands 0.95
    Lower Bollinger Band 0.64
    Percent B (%b) 0.03
    BandWidth 38.76
    MACD Line -0.05
    MACD Signal Line -0.02
    MACD Histogram -0.0219
    Fundamentals Value
    Market Cap 10.39 Million
    Num Shares 16 Million
    EPS -1.73
    Price-to-Earnings (P/E) Ratio -0.38
    Price-to-Sales 0.00
    Price-to-Book 23.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.71
    Resistance 3 (R3) 0.71 0.70 0.70
    Resistance 2 (R2) 0.70 0.68 0.69 0.70
    Resistance 1 (R1) 0.67 0.67 0.67 0.67 0.69
    Pivot Point 0.66 0.66 0.65 0.66 0.66
    Support 1 (S1) 0.63 0.64 0.63 0.63 0.61
    Support 2 (S2) 0.62 0.63 0.62 0.60
    Support 3 (S3) 0.60 0.62 0.60
    Support 4 (S4) 0.59